PRO1107 in Patients With Advanced Solid Tumors
Genmab
Genmab
Pfizer
Pheon Therapeutics
Ocellaris Pharma, Inc.
Seagen Inc.
Sotio Biotech Inc.
Bolt Biotherapeutics, Inc.
Alaunos Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Pfizer
Novartis
Alaunos Therapeutics
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Numab Therapeutics AG
NextCure, Inc.
Elevation Oncology
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Novartis
NantCell, Inc.
NantCell, Inc.
Pfizer
Hoffmann-La Roche
ADC Therapeutics S.A.
ABM Therapeutics Corporation
Pfizer
Mersana Therapeutics
Gilead Sciences
CytomX Therapeutics
Fusion Pharmaceuticals Inc.
SCRI Development Innovations, LLC
pharmaand GmbH
Fate Therapeutics
Duke University
MacroGenics
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
Novartis